CD4 and myocarditis: It has been demonstrated that ONX 0914 reduces the activation of CD4+ T cells by restraining ERK signaling and inducing proteostatic stress in vitro (8) and that CD4+ T cell activation was reduced upon ONX 0914 treatment in a mouse model of myocarditis (57), suggesting a similar mechanism in our setting.